Proactive - Interviews for investors Podcast Por Proactive arte de portada

Proactive - Interviews for investors

Proactive - Interviews for investors

De: Proactive
Escúchala gratis

OFERTA POR TIEMPO LIMITADO | Obtén 3 meses por US$0.99 al mes

$14.95/mes despues- se aplican términos.
Welcome to the Proactive podcast channel – the destination for breaking news on growth companies and up to the minute market coverage. Here we plug you into what’s new and exciting in the world of business. Economía Finanzas Personales Política y Gobierno
Episodios
  • Medicus Pharma to Present Women’s Teverelix Data as SkinJect Phase 2 Approaches Database Lock

    Medicus Pharma to Present Women’s Teverelix Data as SkinJect Phase 2 Approaches Database Lock
    Jan 16 2026
    Medicus Pharma CEO Dr Raza Bokhari joined Steve Darling from Proactive to announce that detailed clinical data for Teverelix, the Company’s long-acting gonadotropin-releasing hormone (GnRH) antagonist, have been accepted for e-Poster presentation at the American Association of Clinical Endocrinology (AACE) Annual Meeting, taking place April 22–24 in Las Vegas, Nevada. The acceptance represents an important milestone in advancing the clinical profile of Teverelix and increasing its visibility within the endocrinology and women’s health communities. Bokhari explained that the accepted abstract, titled “Evaluation of Teverelix,” summarizes results from two randomized, placebo-controlled Phase I clinical studies involving a total of 48 healthy premenopausal women. The studies were designed to assess the drug’s pharmacokinetics and pharmacodynamics, including how Teverelix is absorbed, its ability to suppress key reproductive hormones, its effects on bone turnover markers, and its overall safety following a single subcutaneous injection. Across both studies, participants received single doses of Teverelix at 30 mg, 45 mg, or 60 mg, or placebo, and were monitored for approximately one month. The Phase I results demonstrated rapid and reversible suppression of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), with hormone reductions observed within 24 hours of dosing. Estradiol suppression was dose-dependent and reversible, with multiple participants achieving levels within the clinically relevant Barbieri window of 30–50 pg/mL, a range associated with symptom control while reducing the risk of bone loss. The data also showed sustained pharmacodynamic activity, with hormone suppression lasting up to two to three weeks following a single injection at higher dose levels. Importantly, bone turnover markers remained stable throughout the observation period, suggesting no evidence of short-term bone loss. Teverelix was generally well tolerated, with a favorable safety profile, no drug-related serious adverse events, and only mild-to-moderate treatment-emergent adverse events reported. Bokhari also provided an update on Skinject, the company’s flagship asset targeting non-melanoma skin cancers. He confirmed a 90-patient phase two study is complete, and that Medicus Pharma is approaching a database lock and data analysis phase, with results anticipated to align with strong interim data. #proactiveinvestors #nasdaq #mdcx #tsxv #mdcx #pharma #Biotech #CancerTreatment #ClinicalTrials #FDAApproval #SkinCancer #HealthcareInnovation #Investing #MedicalResearch #SkinCancer #BasalCellCarcinoma #BiotechNews #CancerResearch #GorlinSyndrome #BasalCellCarcinoma #CompassionateUse #FDAApproval #RareDiseaseTreatment #NoninvasiveTherapy #BiotechNews
    Más Menos
    6 m
  • Nextech3D.ai completes BitPay integration, advances phase 2 blockchain platform

    Nextech3D.ai completes BitPay integration, advances phase 2 blockchain platform
    Jan 16 2026
    Nextech3D.ai CEO Evan Gappelberg joined Steve Darling from Proactive to announce that the company has successfully finalized its integration with BitPay, a leading global blockchain payment services company. This milestone, combined with significant backend infrastructure upgrades, further strengthens Nextech3D.ai’s Phase 2 Blockchain Suite across its flagship platforms, including KraftyLab, Map D, and Eventdex. Gappelberg explained that over the past week the company completed a series of critical technical migrations and deployments designed to materially enhance platform stability, performance, and scalability. As part of these efforts, Nextech3D.ai migrated and deployed its backend services to AWS container-based infrastructure supported by a standalone database architecture. This transition is expected to improve resource efficiency by up to 80% compared to traditional deployment methods, while also delivering a highly available, secure, and resilient environment capable of supporting global-scale event operations. In parallel, the company completed integrated smart contract deployment across both backend and frontend systems, ensuring a single, verified contract version for all users. The upgraded blockchain framework now supports both ERC-721 standards for unique digital collectibles and ERC-1155 standards for multi-tier ticketing use cases. This enhanced flexibility allows event organizers to manage a wide range of digital assets—such as VIP, General Admission, and other tiered access products—within a single, cost-efficient smart contract structure. The BitPay integration significantly expands payment flexibility for Nextech3D.ai’s clients, enabling transactions to be settled in more than 100 supported digital assets. Industry data continues to highlight the operational and cost benefits for merchants adopting blockchain-based payments, including faster settlement times and reduced transaction fees. With the foundational AWS migration now complete, Nextech3D.ai is turning its focus to the final components of its Q1 blockchain roadmap. These include configurable royalty-splitting functionality designed to automatically redirect 7% to 10% of secondary resale value back to creators and event organizers, as well as custodial resale capabilities. The custodial resale feature will allow tickets to be resold directly from custodial wallets, removing technical barriers for enterprise and non-crypto-native users and further accelerating mainstream adoption of blockchain-enabled event solutions. #nextech3d.al #otcqx #nexcf #cse #ntar #EvanGappelberg #ARway #AugmentedReality #SpatialMapping #IndoorNavigation #MapDynamics #EventTech #TradeShowSolutions #TechStocks #ARRevenueGrowth #3DTechnology #ProactiveInvestors #aws #amazonwebservice #tickets #kraftylab
    Más Menos
    5 m
  • Rio Tinto Nuton and AWS partner as first copper produced at Johnson Camp

    Rio Tinto Nuton and AWS partner as first copper produced at Johnson Camp
    Jan 15 2026
    Gunnison Copper Corp Chief Operating Officer Robert Winton joined Steve Darling from Proactive to announce a major strategic collaboration between Rio Tinto and Amazon Web Services (AWS), marking a significant milestone for Nuton® Technology. Under the agreement, AWS will become the first customer for Nuton copper following the successful first industrial-scale deployment of the innovative bioleaching technology at Gunnison Copper’s Johnson Camp copper mine in the United States last month. Winton explained that the agreement positions AWS as both an offtake partner and a technology collaborator. AWS will utilize the first Nuton-produced copper in components for its U.S.-based data centers, while also providing cloud-based data, analytics, and digital infrastructure to help accelerate the optimization and scaling of Nuton’s proprietary bioleaching process at the Johnson Camp Mine. Copper is a critical material for data center infrastructure, with applications ranging from electrical cabling and busbars to transformer and motor windings, printed circuit boards, and processor heat sinks. Through this partnership, Nuton is leveraging AWS platforms to simulate heap-leach performance and integrate advanced analytics into its decision-support systems. This digital approach enables more efficient acid and water usage while improving predictive models for copper recovery and overall operational performance. Nuton’s modular bioleaching system extracts copper from primary sulphide material using naturally occurring microorganisms. The modular design, combined with advanced digital tools, allows the technology to be rapidly scaled and tailored to different mineralized bodies, significantly reducing the time from concept to commercial production. The process produces 99.99% pure copper cathode directly at the mine gate, eliminating the need for traditional concentrators, smelters, and refineries, and dramatically shortening the mine-to-market supply chain. Winton noted that the collaboration with AWS and Nuton represents a fundamentally different and more sustainable approach to copper production. By reducing carbon emissions, lowering water consumption, and producing high-purity copper close to end users, the partnership supports both supply chain resilience and decarbonization objectives. As AWS continues to invest in next-generation, carbon-free energy technologies and expand its data center footprint, access to lower-carbon, domestically produced copper strengthens its ability to scale responsibly while supporting innovation across critical infrastructure. #proactiveinvestors #gunnisoncoppercorp #tsx #gcu #otcqb #gcumf r #CopperMining #USMining #CopperProject #MiningInvestment #CommodityMarkets #CopperProduction #ArizonaMining #ResourceDevelopment #MiningStocks #CopperDemand #MetalsAndMining #AmazonWebServices#DataCenterInfrastructure#USMining#CriticalMinerals#Nuton#RioTinto
    Más Menos
    4 m
Todavía no hay opiniones